Article Text

Download PDFPDF
Mosaicism for FMR1 and FMR2 deletion: a new case
  1. S Fengler,
  2. S Fuchs,
  3. R König,
  4. J Arnemann
  1. Institute of Human Genetics, Johann Wolfgang Goethe University Hospital, Theodor-Stern-Kai 7, D-60590 Frankfurt/Main, Germany
  1. Correspondence to:
 Dr J Arnemann, Institute of Human Genetics, Johann Wolfgang Goethe University Hospital, Theodor-Stern-Kai 7, D-60590 Frankfurt/Main, Germany;
 Arnemann{at}em.uni-frankfurt.de

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Fragile X syndrome is the most common disorder causing mental retardation with an estimated prevalence of between 1 in 4000 to 1 in 6000 males.1, 2 In nearly all cases, the molecular basis of this X linked mental impairment is an amplification in excess of 200 copies of an unstable CGG trinucleotide repeat sequence within the 5` untranslated region of the FMR1 gene (FRAXA, MIM 309550) at Xq27.3.3 This causes an inhibition of the transcription leading to a loss of function effect in the male. In the female, the amplified gene is preferentially X inactivated by methylation.4 However, the X inactivation pattern can vary between different cell types and during development and thus, usually, causes a milder phenotype in female patients.5 In close distal proximity to the FMR1 gene, a second gene, FMR2 (FRAXE, MIM 309548) involved in mental retardation, has been described with amplification of an unstable GCC trinucleotide repeat sequence as the underlying pathological mechanism.6 This report adds a further case with mosaicism for a FMR1 and FMR2 deletion to the few described cases with a large FMR1 deletion.7–11

CASE REPORT

A boy of 3½12 years of age was referred to our Clinical Genetics Unit because of severe …

View Full Text